《Science》: Hyaluronic Acid and Tissue Mechanics Synergistically Regulate Mammalian Digit Tip Regeneration
Release time:
2026-06-26
Recently, the international top academic journal Science published online a significant research finding from the team led by Mekayla A. Storer at the University of Cambridge. This study reveals that the composition and mechanical properties of the extracellular matrix (ECM) serve as a critical "switch" determining whether mammalian tissues undergo regeneration or fibrotic scar repair, offering a fresh perspective for regenerative medicine.

Regeneration vs. Scarring: Two Distinct Microenvironments
In mammals (including humans), injuries typically culminate in scar healing, but the digit tip is a rare exception—amputation at the distal phalanx (P3 region) enables complete multi-tissue regeneration, whereas the proximal phalanx (P2 region), closer to the torso, only forms scar tissue.
Using a mouse digit tip amputation model, the research team found that the root of this difference lies in the extracellular matrix microenvironment at the injury site. The non-regenerative region exhibits stiff tissue with a dense, organized collagen network, whereas the regenerative region is softer, more fluid, and rich in hyaluronic acid (HA). Atomic force microscopy measurements confirmed that non-regenerative wounds are significantly stiffer than regenerative blastema tissues.
Hyaluronic Acid: The Core Driver of Regeneration
The study found that hyaluronic acid is not merely a passive matrix component but actively inhibits collagen assembly, preventing fibrosis. When the researchers depleted hyaluronic acid using hyaluronidase or the drug 4-methylumbelliferone (4-MU), the otherwise regenerative distal amputations shifted toward fibrosis—blastema formation was blocked, osteoblasts decreased, and bone repair failed. This series of experiments confirmed that hyaluronic acid is a necessary driver of digit tip regeneration.
HAPLN1: The Key Protein That Rewrites Fate
The team further pinpointed hyaluronic acid and proteoglycan link protein 1 (HAPLN1). HAPLN1 stabilizes the hyaluronic acid network and maintains the soft mechanical properties of the tissue. By overexpressing HAPLN1 in a non-regenerative amputation model, the researchers successfully induced bone tissue regeneration where it had previously been impossible—bone growth extended beyond the original amputation plane, scar-like collagen structures were markedly reduced, and tissue stiffness decreased while fluidity increased.
At the mechanistic level, the study confirmed that a soft matrix environment enhances cellular responsiveness to bone morphogenetic protein (BMP) signaling—fibroblasts cultured on soft matrices exhibited significantly higher pSMAD1/5/8 signaling levels than those on stiff matrices. This explains how the mechanical microenvironment directly regulates cellular regenerative behavior.
From Targeting Cells to Engineering the ECM
This study is the first to systematically elucidate the core mechanism by which ECM composition and mechanical properties act as a "switch" between regeneration and fibrosis in mammals. The team proposes that the perspective of regenerative medicine should shift from "targeting cells" to "engineering the extracellular matrix"—by modulating the physical microenvironment rather than merely intervening in cells, it may be possible to unlock the intrinsic regenerative potential of mammals. This discovery opens entirely new research avenues for anti-fibrotic therapies and tissue repair.
This work was completed by scholars including Mui, Wong, and Storer from the University of Cambridge. In the same issue, Science also published a related study on oxygen-sensing regulation of limb regeneration, collectively providing important breakthroughs in understanding the mechanisms of mammalian regeneration.
Latest developments
Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross
Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.
The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.
Public Welfare Partnership: A Special Letter from the Jinan Red Cross
On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).
World’s First Achievement Highlights Brand Leadership
In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.
Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference
Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.
According to the latest announcement from the International Society of Cryobiology, Professor Xu Yi from the School of Health Science and Engineering at the University of Shanghai for Science and Technology, and a member of the Yinfeng Cryomedicine Expert Committee, has been elected as a Board Governor of the Society for a three-year term (2026–2028). The election was conducted through a democratic vote by all members worldwide, with three new Board Governors elected. Professor Xu Yi is the only scholar from Asia elected to the Society’s Board of Governors this time and the third elected scholar from mainland China in the Society’s 60-year history.